Document Detail

Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.
MedLine Citation:
PMID:  8843494     Owner:  NLM     Status:  MEDLINE    
1. A double-blind controlled crossover trial of 6 gm of inositol daily vs glucose for one month each was carried out in 11 Alzheimer patients. 2. Overall CAMCOG scores showed a trend for greater improvement with inositol that was not significant. 3. Language and orientation improved significantly more on inositol than on placebo. There were no serious side effects. 4. Higher doses of inositol should be studied in Alzheimer's Disease for longer periods.
Y Barak; J Levine; A Glasman; A Elizur; R H Belmaker
Related Documents :
21372704 - High perceived stress is linked to afternoon cortisol levels and greater symptom distre...
20837824 - A randomized pilot clinical trial of the safety of pioglitazone in treatment of patient...
16582044 - Prediction of psychosis onset in alzheimer disease: the role of cognitive impairment, d...
24885384 - Comparing short to standard duration of antibiotic therapy for patients hospitalized wi...
16780494 - A randomised double-blind study comparing the effect of 1072-nm light against placebo f...
2377684 - Effect of exposure to humorous stimuli on induced depression.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Progress in neuro-psychopharmacology & biological psychiatry     Volume:  20     ISSN:  0278-5846     ISO Abbreviation:  Prog. Neuropsychopharmacol. Biol. Psychiatry     Publication Date:  1996 May 
Date Detail:
Created Date:  1997-01-03     Completed Date:  1997-01-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8211617     Medline TA:  Prog Neuropsychopharmacol Biol Psychiatry     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  729-35     Citation Subset:  IM    
Abarbanel Mental Health Center, Bat Yam, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Alzheimer Disease / drug therapy*,  psychology
Cross-Over Studies
Double-Blind Method
Inositol / therapeutic use*
Orientation / physiology
Psychiatric Status Rating Scales
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Metabotropic glutamate receptor subtype 1A activates adenylate cyclase when expressed in baby hamste...
Next Document:  The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: prelimi...